Foundation For Thymic Cancer Research Ardsley, NY - 10502

Foundation For Thymic Cancer Research is categorized under Commercial Medical Research in Ardsley, NY and active since 2009.

Foundation For Thymic Cancer Research was established in 2009, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Alan Neibauer at the company’s single location by writing to 84 Lincoln Avenue, Ardsley, New York NY 10502 or by phoning (914) 693-5498. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Foundation For Thymic Cancer Research
Contact Person: Alan Neibauer
Address: 84 Lincoln Avenue, Ardsley, New York 10502
Phone Number: (914) 693-5498
Annual Revenue (USD): $50.000 to $99.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Foundation For Thymic Cancer Research was started in 2009 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Alan Neibauer for inquiries that concern Foundation For Thymic Cancer Research by calling the company number (914) 693-5498, as your correspondence is most welcome. Additionally, the physical location of the single location of Foundation For Thymic Cancer Research can be found at the coordinates as well as the street address 84 Lincoln Avenue in Ardsley, New York 10502.

For its online presence, you may visit Foundation For Thymic Cancer Research’s website at and engage with its social media outlets through on Twitter and on Facebook.